rxfast.net Quick Pharmacy Navigator

Tag: Paragraph IV certification

Why the First Generic Drug Filer Gets 180 Days of Market Exclusivity
Pharmacy

Why the First Generic Drug Filer Gets 180 Days of Market Exclusivity

  • Gareth Wycliffe
  • Dec 10, 2025

The first generic drug filer gets 180 days of exclusive market rights under the Hatch-Waxman Act. This rule was meant to lower drug prices-but loopholes let companies delay competition. Here’s how it works, who benefits, and why reform is overdue.

Recent Posts
  • Dose-Related vs Non-Dose-Related Side Effects: What’s the Difference in Pharmacology Jun 3, 2026
  • How Liver Failure Affects the Heart: Hemodynamics, Risks, and Care Aug 28, 2025
  • Calcium-Fortified Juice and Medications: The Hidden Binding Risk May 16, 2026
  • Exploring Effective Alternatives to Isotroin for Acne Treatment Dec 19, 2024
  • Nitroglycerin for Angina: How It Works, When to Use It & Dosage Guide Sep 22, 2025
Categories
  • Health (88)
  • Pharmacy (84)
  • Medications (68)
  • Supplements (3)
  • Investments (1)
Tag Clouds
  • online pharmacy
  • medication safety
  • drug interactions
  • generic drugs
  • online pharmacy safety
  • medication adherence
  • generic medications
  • Hatch-Waxman Act
  • therapeutic equivalence
  • GoodRx coupons
  • pharmacovigilance
  • medication side effects
  • 180-day exclusivity
  • DOACs
  • blood thinners
  • bioequivalence
  • telemedicine prescription
  • fertility
  • erectile dysfunction
  • medication
  • About RXFast.net
  • Terms & Conditions
  • Privacy Policy
  • GDPR Compliance Framework
  • Contact Us

©2026 rxfast.net. All rights reserved